# The “Deemed to be a License” Provision of the BPCI Act: Questions and Answers :  Guidance for Industry – FDA Guidance

Source: https://www.keypedia.com/guidances/guidance-document/the-deemed-to-be-a-license-provision-of-the-bpci-act-questions-and-answers-guidance-for-industry/fdd76b2b-bf3b-4f6d-9988-59d75e496a17

> FDA guidance document: The “Deemed to be a License” Provision of the BPCI Act: Questions and Answers :  Guidance for Industry. Issue date: March 04, 2020. Get complete insights and analysis.

---

## Details

- Title: The “Deemed to be a License” Provision of the BPCI Act: Questions and Answers :  Guidance for Industry
- Communication Type: Guidance Document
- Product Type: biologics
- Office Name: Center for Drug Evaluation and Research
- Office URL: /offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c
- Issue Date: 2020-03-04
- Last Changed: 2020-03-04
- Docket Number: <a href="https://www.regulations.gov/docket/FDA-2015-D-4750. ">FDA-2015-D-4750. </a>

## Related Documents

- [Clinical Pharmacology Considerations for Antibody-Drug Conjugates  Guidance for Industry:  Guidance for Industry](https://www.keypedia.com/guidances/guidance-document/clinical-pharmacology-considerations-for-antibody-drug-conjugates-guidance-for-industry-guidance-for-industry/ee3ed09c-6580-489f-bb06-0e93f612d604)
- [Benefit-Risk Assessment for New Drug and Biological Products](https://www.keypedia.com/guidances/guidance-document/benefit-risk-assessment-for-new-drug-and-biological-products/90bf84f4-05cf-4617-b13d-bbb345349aed)
- [Interpretation of the “Deemed to be a License” Provision of the Biologics Price Competition and Innovation Act of 2009 :  Guidance for Industry](https://www.keypedia.com/guidances/guidance-document/interpretation-of-the-deemed-to-be-a-license-provision-of-the-biologics-price-competition-and-innovation-act-of-2009-guidance-for-industry/154bca51-03bf-47a8-8b5d-81c56ff9454a)